| Literature DB >> 23474530 |
Juan Xie1, Wen Wang, Jing-Wen Si, Xing-Yu Miao, Jun-Chang Li, Yao-Chun Wang, Zong-Ren Wang, Jing Ma, Xing-Cheng Zhao, Zhi Li, Hui Yi, Hua Han.
Abstract
Mesenchymal stem cells (MSCs) have been used to repair injured tissues through immune-suppression and/or cell replace mechanisms. However, a significant barrier to MSC therapy is insufficient MSC engraftment in injured tissues after systemic administration. Here, we report that cell surface, total protein, and mRNA levels of CXCR4 were significantly increased in MSCs when Notch signaling was interrupted by γ-secretase inhibitor (GSI) or knockout of the transcription factor RBP-J, which mediates signaling from all four mammalian Notch receptors. The GSI-treated or RBP-J deficient MSCs showed stronger migration toward stromal cell-derived factor-1α (SDF-1α) than that of the control. In a mouse hepatic ischemia/reperfusion model, RBP-J deficient MSCs migrated into the injured liver tissues at a significantly higher efficiency than that of the control MSCs. Mice transfused with RBP-J deficient MSCs showed reduced liver damage. Therefore, Notch signaling regulates MSC migration and function, at least partially via the modulation of CXCR4 expression.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23474530 DOI: 10.1016/j.cellimm.2013.02.001
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868